Total Payments
$7,926
2024 Payments
$175.41
Companies
23
Transactions
51
Medicare Patients
6,193
Medicare Billing
$664,786
Payment Breakdown by Category
Consulting$5,640 (71.2%)
Food & Beverage$2,286 (28.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,640 | 1 | 71.2% |
| Food and Beverage | $2,286 | 50 | 28.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma AS | $5,640 | 1 | $0 (2021) |
| Galderma Laboratories, L.P. | $337.56 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $249.58 | 5 | $0 (2023) |
| Incyte Corporation | $205.01 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $190.59 | 6 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $178.30 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $137.45 | 5 | $0 (2024) |
| Biofrontera Inc. | $129.65 | 7 | $0 (2024) |
| Allergan Inc. | $123.62 | 1 | $0 (2017) |
| ABBVIE INC. | $117.19 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.41 | 7 | Incyte Corporation ($56.03) |
| 2023 | $844.56 | 24 | Regeneron Healthcare Solutions, Inc. ($195.02) |
| 2022 | $353.41 | 7 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2021 | $5,671 | 3 | LEO Pharma AS ($5,640) |
| 2020 | $11.19 | 1 | Kowa Pharmaceuticals America, Inc. ($11.19) |
| 2019 | $396.03 | 5 | Ortho Dermatologics, a division of Bausch Health US, LLC ($178.30) |
| 2018 | $206.09 | 2 | Galderma Laboratories, L.P. ($192.04) |
| 2017 | $269.14 | 2 | Galderma Laboratories, L.P. ($145.52) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: DERMATOLOGY | ||||||
| 03/26/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $29.35 | General |
| Category: DERMATOLOGY | ||||||
| 03/06/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: Coronary | ||||||
| 02/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Coronary | ||||||
| 01/18/2024 | Incyte Corporation | ZYNYZ (Drug) | Food and Beverage | Cash or cash equivalent | $26.78 | General |
| Category: Oncology | ||||||
| 01/12/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $29.25 | General |
| Category: Oncology | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Oncology | ||||||
| 12/14/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2023 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $116.12 | General |
| Category: Oncology | ||||||
| 11/27/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $101.25 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Baxter Healthcare | TISSEEL (Device) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: Surgical Care | ||||||
| 11/15/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2023 | Puma Biotechnology, Inc. | — | Food and Beverage | In-kind items and services | $27.56 | General |
| 09/26/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: DERMATOLOGY | ||||||
| 09/14/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $30.98 | General |
| 08/08/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $33.11 | General |
| 07/20/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2023 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/07/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Monoclonal Antibody | ||||||
| 05/24/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,139 | 1,425 | $716,161 | $117,102 |
| 2022 | 21 | 945 | 1,318 | $1.0M | $86,887 |
| 2021 | 26 | 2,027 | 3,191 | $2.4M | $235,218 |
| 2020 | 26 | 2,082 | 3,162 | $2.5M | $225,579 |
Total Patients
6,193
Total Services
9,096
Medicare Billing
$664,786
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 244 | 244 | $112,484 | $26,291 | 23.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Facility | 2023 | 138 | 185 | $96,015 | $15,171 | 15.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Facility | 2023 | 43 | 53 | $113,950 | $14,695 | 12.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Facility | 2023 | 31 | 40 | $85,480 | $10,863 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 86 | 127 | $38,227 | $10,357 | 27.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 42 | 52 | $53,028 | $7,241 | 13.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Facility | 2023 | 24 | 30 | $40,830 | $4,842 | 11.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 84 | 98 | $21,074 | $4,491 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 59 | 59 | $17,877 | $3,770 | 21.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Facility | 2023 | 21 | 21 | $24,028 | $3,337 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 47 | 57 | $11,628 | $3,018 | 26.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 20 | 20 | $24,510 | $2,814 | 11.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 58 | 86 | $7,396 | $2,701 | 36.5% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 86 | 99 | $32,148 | $2,695 | 8.4% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Facility | 2023 | 11 | 12 | $15,612 | $1,791 | 11.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 50 | 57 | $7,125 | $1,682 | 23.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Facility | 2023 | 16 | 18 | $7,452 | $634.23 | 8.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 20 | 25 | $4,600 | $460.79 | 10.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 59 | 142 | $2,698 | $248.04 | 9.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 61 | 67 | $232,490 | $18,452 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 177 | $96,465 | $12,547 | 13.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 30 | 41 | $84,460 | $6,632 | 7.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 32 | 38 | $80,180 | $5,862 | 7.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 17 | 21 | $68,145 | $5,647 | 8.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 70 | 72 | $60,120 | $4,968 | 8.3% |
About Dr. Steven Wang, MD
Dr. Steven Wang, MD is a MOHS-Micrographic Surgery healthcare provider based in Basking Ridge, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265511968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Wang, MD has received a total of $7,926 in payments from pharmaceutical and medical device companies, with $175.41 received in 2024. These payments were reported across 51 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($5,640).
As a Medicare-enrolled provider, Wang has provided services to 6,193 Medicare beneficiaries, totaling 9,096 services with total Medicare billing of $664,786. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Basking Ridge, NJ
- Active Since 11/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1265511968
Products in Payments
- LIBTAYO (Biological) $249.58
- SILIQ (Drug) $178.30
- SOOLANTRA (Drug) $145.52
- KEYTRUDA (Biological) $137.45
- OPZELURA (Drug) $132.27
- Sotyktu (Drug) $125.00
- ACZONE (Drug) $123.62
- UBRELVY (Drug) $117.19
- KIMMTRAK (Drug) $116.12
- Otezla (Drug) $115.91
- AMELUZ (Drug) $115.60
- DUPIXENT (Drug) $90.64
- FFRct (Device) $51.05
- OPDIVO (Biological) $49.07
- TISSEEL (Device) $37.49
- Poteligeo (Drug) $29.98
- MONJUVI (Drug) $29.25
- ZYNYZ (Drug) $26.78
- Livalo (Drug) $22.37
- SPECTRA WAVEWRITER (Device) $18.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.